Profile data is unavailable for this security.
About the company
abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of life sciences companies. The Fund invests primarily in securities of public and private companies. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.
- Revenue in USD (TTM)1.94m
- Net income in USD85.59m
- Incorporated1992
- Employees--
- Locationabrdn Life Sciences Investors1900 Market Street, Suite 200PHILADELPHIA 19103United StatesUSA
- Phone+1 (617) 772-8515
- Websitehttps://www.aberdeeninvestments.com/en-us/investor/funds/view-all-funds/abrdn-life-sciences-investors-us87911k1007?subTab=keyInformationTab&tab=fundFactsTab
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Voya Global Equity Div and Prem Oppty Fd | 59.75m | 55.07m | 473.21m | -- | 8.59 | 0.9647 | -- | 7.92 | 0.6983 | 0.6983 | 0.7576 | 6.22 | 0.1205 | -- | 32.00 | -- | 11.11 | 7.54 | 11.32 | 7.64 | 93.16 | 90.21 | 92.17 | 88.88 | -- | -- | 0.00 | 55.36 | 104.54 | -- | 119.67 | -- | -- | -0.5337 |
| John Hancock Preferred Income Fund III | -100.00bn | -100.00bn | 474.60m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Rice Acquisition Corp 3 | -100.00bn | -100.00bn | 474.75m | -- | -- | -- | -- | -- | -- | -- | -- | -0.0014 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.34 | -- | -- | -- | -- | -- | -- | -- |
| Invesco Senior Income Trust | -100.00bn | -100.00bn | 475.63m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nuveen Variable Rate Pred & Inc Fund | 46.57m | 46.84m | 475.79m | -- | 10.16 | 0.9815 | -- | 10.22 | 1.94 | 1.94 | 1.93 | 20.06 | 0.0605 | -- | 149.10 | -- | 6.09 | -- | 7.17 | -- | 50.99 | -- | 100.57 | -- | -- | -- | 0.2807 | -- | 9.08 | -- | -28.34 | -- | -- | -- |
| Nuveen Taxable Municipal Income Fund | 41.45m | 10.65m | 481.78m | -- | 45.23 | 0.9956 | -- | 11.62 | 0.3624 | 0.3624 | 1.41 | 16.46 | 0.0564 | -- | 11.68 | -- | 1.45 | 1.72 | 2.00 | 2.41 | 60.72 | 68.26 | 25.70 | 34.07 | -- | 1.74 | 0.3276 | 236.66 | 2.79 | -0.5516 | -27.56 | -- | -- | -1.14 |
| abrdn Life Sciences Investors | 1.94m | 85.59m | 492.82m | -- | 6.07 | 0.9594 | -- | 254.24 | 2.74 | 2.74 | 0.0655 | 17.35 | 0.004 | -- | 2.83 | -- | 17.54 | 6.63 | 17.58 | 6.71 | -169.00 | -79.23 | 4,415.75 | 1,040.39 | -- | -- | 0.00 | 132.40 | -51.30 | -10.59 | 0.3492 | -7.00 | -- | -- |
| Eaton Vnc Tax-Advtgd Glbl Dvdnd Oppnt Fd | -100.00bn | -100.00bn | 494.92m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| New America Acquisition I Corp | -100.00bn | -100.00bn | 500.24m | -- | -- | -- | -- | -- | -- | -- | -- | -0.0001 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.02 | -- | -- | -- | -- | -- | -- | -- |
| Strive Inc | 2.10m | -212.99m | 500.61m | 9.00 | -- | 2.45 | -- | 238.41 | -17.23 | -17.23 | 0.1852 | 3.24 | 0.0053 | -- | -- | 233,307.80 | -53.55 | -- | -54.22 | -- | -- | -- | -10,139.54 | -- | -- | -2.71 | 0.00 | -- | 128.66 | -- | -30.76 | -- | -- | -- |
| Blackstone Strategic Credit 2027 Trm Fnd | 82.01m | 45.74m | 505.60m | -- | 11.05 | 0.8922 | -- | 6.17 | 1.02 | 1.02 | 1.84 | 12.69 | 0.0823 | -- | 1.60 | -- | 4.59 | 2.29 | 5.09 | 2.48 | 58.61 | 65.45 | 55.77 | 32.67 | -- | 20.15 | 0.3649 | 194.05 | 5.28 | -0.133 | -30.77 | -0.5702 | -- | -1.55 |
| First Trust High Yld Oprtnts 2027 Trm Fd | 51.36m | 37.57m | 511.14m | -- | 13.61 | 0.93 | -- | 9.95 | 1.02 | 1.02 | 1.40 | 14.95 | 0.0692 | -- | 3.00 | -- | 5.06 | -- | 5.16 | -- | 62.78 | -- | 73.15 | -- | -- | -- | 0.2498 | -- | -1.99 | -- | -15.87 | -- | -- | -- |
| PIMCO California Municipal Income Fund | -100.00bn | -100.00bn | 511.97m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| abrdn World Healthcare Fund | 11.04m | 55.39m | 513.94m | -- | 9.53 | 1.00 | -- | 46.54 | 1.34 | 1.34 | 0.274 | 12.71 | 0.0177 | -- | 17.12 | -- | 8.85 | 6.79 | 8.90 | 6.88 | -16.86 | 3.32 | 501.55 | 347.23 | -- | -- | 0.1897 | 125.38 | -12.83 | -1.85 | -40.67 | -1.88 | -- | 0.00 |
Data as of Mar 02 2026. Currency figures normalised to abrdn Life Sciences Investors's reporting currency: US Dollar USD
19.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Saba Capital Management LPas of 19 Feb 2026 | 1.46m | 5.07% |
| Penserra Capital Management LLCas of 31 Dec 2025 | 875.13k | 3.03% |
| Parametric Portfolio Associates LLCas of 31 Dec 2025 | 608.01k | 2.11% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 533.56k | 1.85% |
| LPL Financial LLCas of 31 Dec 2025 | 448.85k | 1.56% |
| Raymond James & Associates, Inc. (Invt Mgmt)as of 31 Dec 2025 | 407.38k | 1.41% |
| Needham Investment Management LLCas of 31 Dec 2025 | 403.36k | 1.40% |
| Flagship Harbor Advisors LLCas of 31 Dec 2025 | 363.38k | 1.26% |
| Allspring Global Investments LLCas of 31 Dec 2025 | 230.44k | 0.80% |
| RiverNorth Capital Management LLCas of 31 Dec 2025 | 198.73k | 0.69% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
